Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Georg Buchner

Premium

Silence Therapeutics has named Georg Buchner as vice president of business development.

In this role, he will work with the company's chief business officer to broaden its collaborations with pharmaceutical and biotech firms.

He previously served as vice president of corporate and business development at Novacta Biosystems.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.